Bill Snyder Archive — Page 51 of 119
-
January 23, 2020
Antibody isolated at VUMC found to halt dengue virus
Using part of an antibody isolated at Vanderbilt that “broadly neutralizes” the human dengue virus, biologists at the University of California San Diego and colleagues have disarmed the mosquito that transmits the disabling and potentially deadly tropical infection. -
January 16, 2020
VUMC study sheds light on gastric cancer development
VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development. -
December 31, 2019
Kavalali receives Humboldt Research Award
Ege T. Kavalali, PhD, professor and acting chair of the Department of Pharmacology in the Vanderbilt University School of Medicine, has been elected a recipient of a prestigious Humboldt Research Award by the Alexander von Humboldt Foundation of Germany. -
December 12, 2019
VUMC-led team isolates antibody that blocks bird flu
VUMC scientists are redoubling their efforts to help people fight off bird flu. Their focus is H7N9, one of the most dangerous of the influenza viruses that have been transmitted from birds to humans. -
December 12, 2019
Study examines HIV drug’s potential to treat Alzheimer’s
A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease. -
December 11, 2019
VUMC’s Denny selected to lead national ‘All of Us’ program
The National Institutes of Health (NIH) has selected Joshua Denny, MD, MS, vice president of Personalized Medicine at Vanderbilt University Medical Center, to be the chief executive officer of the federal All of Us Research Program.